By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Tokyo      Japan
Phone: 81-3-3485-7707 Fax: n/a



Company News
Teijin Pharma To Collaborate With Peptidream In Peptide Discovery 9/28/2015 9:59:20 AM
Peptidream Announces Peptide Discovery Collaboration Agreement With Sanofi (SNY) 9/14/2015 12:42:30 PM
Peptidream Announces Milestone In Macrocyclic Peptide Drug Discovery Alliance With Bristol-Myers Squibb (BMY) 6/11/2015 10:27:02 AM
Peptidream Announces Peptide Discovery Collaboration Agreement With Merck & Co. (MRK) 5/1/2015 10:18:38 AM
Peptidream Announces License Of PeptiDream's Peptide Discovery Platform System (PDPS) Technology To Peptidream 4/2/2015 10:58:17 AM
Taiyo Pacific Partners Becomes Major Shareholder In Peptidream With Stake Over 5% 11/4/2014 10:19:06 AM
Peptidream Announces Extension And Advancement Of A Peptide Discovery Program 10/3/2014 10:19:32 AM
Peptidream Announces The Appointment Of Dr. Keiichi Masuya As Chief Operating Officer (COO) At Peptidream Inc. 7/17/2014 11:31:46 AM
Peptidream Announces The Development Of A New Broad Strain Anti-Influenza Macrocyclic Peptide Therapeutic 4/8/2014 9:34:29 AM
Peptidream Announces Collaboration And License Agreement With Eli Lilly and Company (LLY) To Discover Macrocyclic Peptide Drug Candidates 12/20/2013 6:56:54 AM